INTUITIVE SURGICAL, INC. Funds and ETFs Intuitive Surgical, Inc.
Equities
ISRG
US46120E6023
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 399.7 USD | -0.09% |
|
+3.96% | +18.39% |
| May. 17 | Intuitive Surgical Insider Sold Shares Worth $1,021,200, According to a Recent SEC Filing | MT |
| May. 16 | Everlasting momentum |  |
ETFs positioned on Intuitive Surgical, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.76% | 17 M€ | +7.97% | - | |
| 1.86% | 144 M€ | +1.33% | - | |
| 1.52% | 105 M€ | 0.00% | - | |
| 1.22% | 92 M€ | +0.06% | - | |
| 1.22% | 1 M€ | -.--% | - | |
| 1.15% | 10 M€ | +6.14% | - | |
| 1.14% | 12 M€ | +15.09% | - | |
| 1.14% | 2 M€ | -1.17% | - | |
| 1.10% | 85 M€ | +1.68% | ||
| 1.07% | 14 M€ | -2.76% | ||
| 0.96% | 1,100 M€ | +4.55% | ||
| 0.89% | 5 M€ | -72.95% | - | |
| 0.88% | 9 M€ | -.--% | - | |
| 0.88% | 110 M€ | +10.57% | - | |
| 0.87% | 3 M€ | 0.00% | - | |
| 0.84% | 20 M€ | -.--% | - | |
| 0.83% | 37 M€ | -.--% | ||
| 0.82% | 115 M€ | +5.08% | - | |
| 0.77% | 265 M€ | +7.06% | - | |
| 0.66% | 15 M€ | 0.00% | - | |
| 0.49% | 85 M€ | +14.30% | - | |
| 0.43% | 727 M€ | +9.56% | ||
| 0.42% | 9 M€ | +15.45% | - | |
| 0.40% | 1 M€ | +0.04% | ||
| 0.40% | 36 M€ | +22.19% | ||
| 0.39% | 8 M€ | +5.66% | ||
| 0.32% | 368 M€ | +22.22% | - |
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows:
- sale of instruments and accessories (60%): primarily wrist cuffs;
- sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries;
- installation and training services (16.4%).
The United States accounts for 65.8% of net sales.
Calendar
2024-07-17
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
400
USD
Average target price
420.4
USD
Spread / Average Target
+5.09%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.39% | 142B | |
| +10.53% | 227B | |
| +15.31% | 198B | |
| +31.12% | 111B | |
| +1.56% | 64.16B | |
| +18.34% | 54.1B | |
| +5.12% | 51.41B | |
| +10.65% | 45.32B | |
| +5.38% | 37.32B | |
| +26.39% | 32.13B |
- Stock Market
- Equities
- ISRG Stock
- Funds and ETFs Intuitive Surgical, Inc.